An interlaboratory comparison of physiological and genetic properties of four Saccharomyces cerevisiae strains.
By J. V. Dijken, J. Bauer, L. Brambilla, P. Duboc, J. François, C. Gancedo, M. Giuseppin, J. Heijnen, M. Hoare, H. Lange and 13 more. Enzyme and Microbial Technology, 2000
600 citations recorded by the source corpus.
Subfields: Biomedical Engineering, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/2c48be80ea5fc199a63d9c12e6eb82e174cc25f2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
In Molecular Biology
Citations in the corpus
- Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin (2012, background): “PK2 Gen 1.0 strain bearing pAM322 (Y135; 70% stable after 72 h growth in flasks).”
- Leakage-free rapid quenching technique for yeast metabolomics (2008, unknown): “PK 113-7D (MATa) (van Dijken et al. 2000).”
- Arabinose and xylose fermentation by recombinant Saccharomyces cerevisiae expressing a fungal pentose utilization pathway (2009, unknown): “the original host strain CEN.PK 113-16B [ 47 ] (data not shown).”
- Progress in Metabolic Engineering of Saccharomyces cerevisiae (2008, background): “The use of oxygen tension as a trigger for gene expression is attractive because (i) oxygen supply is limited in industrial fermentations, particularly at high biomass concentrations; (ii) ATP supply could be optimized for yeast biomass formation during the aerobic phase (360); and (iii) fermentativ”